Akt/mTOR Signaling in Energy Balance Modulation of Epithelial Carcinogenesis
Akt/mTOR Signaling in Energy Balance Modulation of Epithelial Carcinogenesis
批准号:
8444652
负责人:
Stephen D Hursting
金额:
$28.95万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2014-08-28
关键词:
AdultBiochemicalCaloric RestrictionCell Cycle ProteinsCellsCyclin D1DevelopmentDietEpidermal Growth Factor ReceptorEpidermisEpithelialFamilyFutureGene ExpressionGeneticGrowthGrowth FactorHealthHumanInsulin-Like Growth Factor ILeadLinkLiverMalignant NeoplasmsModelingMolecularMusObesityPathway interactionsPhorbol EstersPhosphorylationPlayPrevalencePrevention strategyPreventivePropertyRegulationRelative (related person)Risk FactorsRoleSalineSignal PathwaySignal TransductionSirolimusSkinSkin NeoplasmsStagingStem cellsTestingTissuesTransgenic MiceTumor PromotionWild Type Mousebasecancer preventioncancer stem cellcancer typecarcinogenesisenergy balancefeedinghuman FRAP1 proteininhibitor/antagonistinsightkeratinocytekinase inhibitormTOR Inhibitormicrobial alkaline proteinase inhibitorpreventreceptorresearch studysoundtranscription factortranslational studytumorigenesis
中文摘要
描述(由申请人提供):卡路里限制(CR)可以预防成人发病的肥胖,并抑制多种物种的实验性致癌作用。不幸的是,人们对这些CR效应的机制知之甚少。肥胖是许多类型癌症的危险因素,鉴于肥胖的患病率不断上升,迫切需要深入了解CR的作用机制,以制定新的癌症预防策略。我们最近对A-ZIP/F1和Akt转基因小鼠的研究表明,Akt和mTOR信号通路在小鼠皮肤上皮癌变过程中起重要作用。此外,我们已经证明:1)CR降低Akt和mTOR的活性,包括在包括表皮在内的几种组织中IGF-1受体(IGF-1R)和表皮生长因子(EGF)-R的磷酸化降低;ii)肝脏特异性IGF-1缺乏(LID,导致循环IGF-1水平降低)通过抑制皮肤肿瘤的促进和通过IGF-1R/EGFR及随后的下游信号通路,包括Akt和mTOR,模拟CR。此外,我们发现CR降低了表皮细胞周期蛋白D1并增加了p27的水平。这些发现提示了CR通过IGF-1R和EGF-R减少信号通路,通过多种信号通路(包括Akt和mTOR)减少下游信号通路,最终通过调节细胞周期调节蛋白导致增殖减少的假设。我们将专门研究Akt和mTOR通路在这些CR效应中的重要性。我们建议使用具有良好特征的上皮癌变两阶段皮肤模型,结合饮食、遗传和药理学方法来验证这一假设。具体目的是:1)确定操纵饮食能量平衡对TPA诱导的野生型和肝脏igf -1缺陷小鼠皮肤肿瘤促进的影响;2)研究饮食能量平衡调控对表皮细胞信号通路和基因表达的影响;3)研究CR对皮肤肿瘤促进作用的机制;4)表征雷帕霉素(mTOR的选择性抑制剂)、API-2 (Akt的选择性抑制剂)和NVP-AE451 (IGF-1受体的选择性抑制剂)对自由喂养或CR小鼠皮肤肿瘤促进的预防作用。成功建立了CR与IGF- 1R/Akt/mTOR通路在上皮癌变中的抗癌作用之间的因果关系,将为转化研究提供良好的基础,以确定靶向该通路是否是预防人类上皮癌的策略。
英文摘要
DESCRIPTION (provided by applicant): Calorie restriction (CR) prevents adult-onset obesity and suppresses experimental carcinogenesis in multiple species. Unfortunately, the mechanisms underlying these CR effects are poorly understood. Given the rising prevalence of obesity, an established risk factor for many types of cancer, mechanistic insights into the effects of CR are urgently needed to develop new cancer prevention strategies. Our recent studies using A-ZIP/F1 and Akt transgenic mice have demonstrated an important role for Akt and mTOR signaling in epithelial carcinogenesis in mouse skin. Furthermore, we have shown that i) CR decreases activity of Akt and mTOR, including reduced phosphorylation of the IGF-1 receptor (IGF-1R) and epidermal growth factor (EGF)-R, in several tissues including the epidermis; and ii) liver-specific IGF-1 deficiency (LID, resulting in reduced circulating IGF-1 levels) mimics CR by inhibiting skin tumor promotion and signaling through the IGF-1R/EGFR and subsequent downstream signaling pathways, including Akt and mTOR in mice. Furthermore, we have found that CR reduces cyclin D1 and increases p27 levels in epidermis. These findings suggest the hypothesis that CR reduces signaling through the IGF-1R and EGF-R, decreasing downstream signaling through multiple signaling pathways (including Akt and mTOR), ultimately leading to decreased proliferation through modulation of cell cycle regulatory proteins. We will specifically examine the importance of the Akt and mTOR pathways in these effects of CR. We propose to use the well-characterized two-stage skin model of epithelial carcinogenesis, in combination with dietary, genetic, and pharmacologic approaches, to test this hypothesis. The specific aims are to The specific aims are to: 1) Determine the impact of manipulation of dietary energy balance on phorbol ester (TPA)-induced skin tumor promotion in wild-type and liver IGF-1-deficient mice; 2) Examine cell signaling pathways and alterations in gene expression in epidermis resulting from dietary energy balance manipulations; 3) Examine mechanisms underlying the effects of CR on skin tumor promotion; and 4) Characterize the preventive effects of rapamycin (a selective inhibitor of mTOR), API-2 (a selective Akt inhibitor) and NVP-AE451 (a selective inhibitor of the IGF-1 receptor) on skin tumor promotion in ad libitum-fed or CR mice. The successful establishment of a causal link between the anticancer effects of CR and the IGF- 1R/Akt/mTOR pathway in epithelial carcinogenesis will provide a sound basis for translational studies to determine if targeting this pathway is a strategy for preventing epithelial cancers in humans.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3389/fonc.2013.00209
发表时间:
2013
期刊:
Frontiers in oncology
影响因子:
4.7
作者:
[Ford NA, Lashinger LM, Allott EH, Hursting SD]
通讯作者:
Hursting SD
DOI:
10.1158/1940-6207.capr-14-0335
发表时间:
2015-10
期刊:
Cancer prevention research (Philadelphia, Pa.)
影响因子:
--
作者:
[Fabian CJ, Kimler BF, Phillips TA, Box JA, Kreutzjans AL, Carlson SE, Hidaka BH, Metheny T, Zalles CM, Mills GB, Powers KR, Sullivan DK, Petroff BK, Hensing WL, Fridley BL, Hursting SD]
通讯作者:
Hursting SD
DOI:
10.1158/1940-6207.capr-13-0110
发表时间:
2014-01
期刊:
Cancer prevention research (Philadelphia, Pa.)
影响因子:
--
作者:
[Checkley LA, Rho O, Angel JM, Cho J, Blando J, Beltran L, Hursting SD, DiGiovanni J]
通讯作者:
DiGiovanni J
Minireview: the year in obesity and cancer.
小评论:肥胖和癌症的一年。
DOI:
10.1210/me.2012-1283
发表时间:
2012
期刊:
Molecular endocrinology (Baltimore, Md.)
影响因子:
--
作者:
[Hursting,StephenD]
通讯作者:
Hursting,StephenD
Impact of hypoxia on lipid metabolism in obesity-driven breast cancer progression
-
批准号:10604919
-
项目类别:
-
资助金额:$65.54万
-
财政年份:2022
-
负责人:Stephen D Hursting
-
依托单位:
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link
-
批准号:10229282
-
项目类别:
-
资助金额:$67.71万
-
财政年份:2021
-
负责人:Stephen D Hursting
-
依托单位:
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link
-
批准号:10683262
-
项目类别:
-
资助金额:$62.75万
-
财政年份:2021
-
负责人:Stephen D Hursting
-
依托单位:
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link
-
批准号:10493126
-
项目类别:
-
资助金额:$62.14万
-
财政年份:2021
-
负责人:Stephen D Hursting
-
依托单位:
Obesity, Metabolism and Breast Cancer Metastasis
-
批准号:10381300
-
项目类别:
-
资助金额:$11.66万
-
财政年份:2021
-
负责人:Stephen D Hursting
-
依托单位:
Obesity, Metabolism and Breast Cancer Metastasis
-
批准号:10548139
-
项目类别:
-
资助金额:$44.96万
-
财政年份:2019
-
负责人:Stephen D Hursting
-
依托单位:
Obesity, Metabolism and Breast Cancer Metastasis
-
批准号:10524122
-
项目类别:
-
资助金额:$18.63万
-
财政年份:2019
-
负责人:Stephen D Hursting
-
依托单位:
Obesity, Metabolism and Breast Cancer Metastasis
-
批准号:10319580
-
项目类别:
-
资助金额:$44.96万
-
财政年份:2019
-
负责人:Stephen D Hursting
-
依托单位:
Obesity, Metabolism and Breast Cancer Metastasis
-
批准号:9759569
-
项目类别:
-
资助金额:$47.25万
-
财政年份:2019
-
负责人:Stephen D Hursting
-
依托单位:
Obesity, Metabolism and Breast Cancer Metastasis
-
批准号:10079476
-
项目类别:
-
资助金额:$45.88万
-
财政年份:2019
-
负责人:Stephen D Hursting
-
依托单位:
Breaking the Obesity-Cancer Link: New Targets and Strategies
-
批准号:8956135
-
项目类别:
-
资助金额:$76.26万
-
财政年份:2015
-
负责人:Stephen D Hursting
-
依托单位:
Breaking the Obesity-Cancer Link: New Targets and Strategies
-
批准号:9117547
-
项目类别:
-
资助金额:$76.26万
-
财政年份:2015
-
负责人:Stephen D Hursting
-
依托单位:
Breaking the Obesity-Cancer Link: New Targets and Strategies
-
批准号:9764294
-
项目类别:
-
资助金额:$72.69万
-
财政年份:2015
-
负责人:Stephen D Hursting
-
依托单位:
Akt/mTOR Signaling in Energy Balance Modulation of Epithelial Carcinogenesis
-
批准号:8223255
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2009
-
负责人:Stephen D Hursting
-
依托单位:
Akt/mTOR Signaling in Energy Balance Modulation of Epithelial Carcinogenesis
-
批准号:7655953
-
项目类别:
-
资助金额:$33.05万
-
财政年份:2009
-
负责人:Stephen D Hursting
-
依托单位:
Akt/mTOR Signaling in Energy Balance Modulation of Epithelial Carcinogenesis
-
批准号:8027757
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2009
-
负责人:Stephen D Hursting
-
依托单位:
Akt/mTOR Signaling in Energy Balance Modulation of Epithelial Carcinogenesis
-
批准号:7821406
-
项目类别:
-
资助金额:$31.75万
-
财政年份:2009
-
负责人:Stephen D Hursting
-
依托单位:
Animal Metabolism Phenotyping Core
-
批准号:10170771
-
项目类别:
-
资助金额:$15.55万
-
财政年份:1999
-
负责人:Stephen D Hursting
-
依托单位:
Animal Metabolism Phenotyping Core
-
批准号:10601026
-
项目类别:
-
资助金额:$14.71万
-
财政年份:1999
-
负责人:Stephen D Hursting
-
依托单位:
Animal Metabolism Phenotyping Core
-
批准号:10373074
-
项目类别:
-
资助金额:$14.95万
-
财政年份:1999
-
负责人:Stephen D Hursting
-
依托单位:
海外基金